Metabolic pathways enzyme/substrate

There are many interconnections between the main metabolic pathways. Many substrates and regulatory molecules, and some enzymes, are common to several pathways. An understanding of these interconnections requires knowledge of (1) the subcellular locations and concentrations of the enzymes involved, (2) the concentrations of metabolites within different subcellular organelles, and (3) the nature of permeability barriers for metabolites between the organelles these barriers divide the cell into a number or compartments for each metabolite. 

Metabolic pathway Enzymes Photometric substrates Fluorogenic substrates... 

Microorganisms exhibit nutritional preferences. The enzymes for common substrates such as glucose are usually constitutive, as are the enzymes for common or essential metabohc pathways. Furthermore, the synthesis of enzymes for attack on less common substrates such as lactose is repressed by the presence of appreciable amounts of common substrates or metabolites. This is logical for cells to consei ve their resources for enzyme synthesis as long as their usual substrates are readily available. If presented with mixed substrates, those that are in the main metabolic pathways are consumed first, while the other substrates are consumed later after the common substrates are depleted. This results in diauxic behavior. A diauxic growth cui ve exhibits an intermediate growth plateau while the enzymes needed for the uncommon substrates are synthesized (see Fig. 24-2). There may also be preferences for the less common substrates such that a mixture shows a sequence of each being exhausted before the start of metabolism of the next. 

FIGURE 18.5 Schematic representation of types of multienzyme systems carrying out a metabolic pathway (a) Physically separate, soluble enzymes with diffusing intermediates, (b) A multienzyme complex. Substrate enters the complex, becomes covalently bound and then sequentially modified by enzymes Ei to E5 before product is released. No intermediates are free to diffuse away, (c) A membrane-bound multienzyme system. 

In nature, aminotransferases participate in a number of metabolic pathways [4[. They catalyze the transfer of an amino group originating from an amino acid donor to a 2-ketoacid acceptor by a simple mechanism. First, an amino group from the donor is transferred to the cofactor pyridoxal phosphate with formation of a 2-keto add and an enzyme-bound pyridoxamine phosphate intermediate. Second, this intermediate transfers the amino group to the 2-keto add acceptor. The readion is reversible, shows ping-pong kinetics, and has been used industrially in the production ofamino acids [69]. It can be driven in one direction by the appropriate choice of conditions (e.g. substrate concentration). Some of the aminotransferases accept simple amines instead of amino acids as amine donors, and highly enantioselective cases have been reported [70]. 

Metabolic pathways containing dioxygenases in wild-type strains are usually related to detoxification processes upon conversion of aromatic xenobiotics to phenols and catechols, which are more readily excreted. Within such pathways, the intermediate chiral cis-diol is rearomatized by a dihydrodiol-dehydrogenase. While this mild route to catechols is also exploited synthetically [221], the chirality is lost. In the context of asymmetric synthesis, such further biotransformations have to be prevented, which was initially realized by using mutant strains deficient in enzymes responsible for the rearomatization. Today, several dioxygenases with complementary substrate profiles are available, as outlined in Table 9.6. Considering the delicate architecture of these enzyme complexes, recombinant whole-cell-mediated biotransformations are the only option for such conversions. E. coli is preferably used as host and fermentation protocols have been optimized [222,223]. 

A new tool for computational ADME/Tox called MetaDrug includes a manually annotated Oracle database of human drug metabolism information including xenobiotic reactions, enzyme substrates, and enzyme inhibitors with kinetic data. The MetaDrug database has been used to predict some of the major metabolic pathways and identify the involvement of P450s [78]. This database has enabled the generation of over 80 key metabolic... 

After reuptake into the cytosol, some noradrenaline may be taken up into the storage vesicles by the vesicular transporter and stored in the vesicles for subsequent release (see above). However, it is thought that the majority is broken down within the cytosol of the nerve terminal by monoamine oxidase (MAO ECl.4.3.4). A second degradative enzyme, catechol-O-methyl transferase (COMT EC2.1.1.6), is found mostly in nonneuronal tissues, such as smooth muscle, endothelial cells or glia. The metabolic pathway for noradrenaline follows a complex sequence of alternatives because the metabolic product of each of these enzymes can act as a substrate for the other (Fig 8.8). This could enable one of these enzymes to compensate for a deficiency in the other to some extent. 

The NHase responsible for aldoxime metabolism from the i -pyridine-3-aldoxime-degrading bacterium, Rhodococcus sp. strain YH3-3, was purified and characterized. Addition of cobalt ion was necessary for the formation of enzyme. The native enzyme had a Mr of 130000 and consisted of two subunits (a-subunit, 27 100 (3-subunit, 34500). The enzyme contained approximately 2 mol cobalt per mol enzyme. The enzyme had a wide substrate specificity it acted on aliphatic saturated and unsaturated as well as aromatic nitriles. The N-terminus of the (3-subunit showed good sequence similarities with those of other NHases. Thus, this NHase is part of the metabolic pathway for aldoximes in microorganisms. 

A common characteristic of metabolic pathways is that the product of one enzyme in sequence is the substrate for the next enzyme and so forth. In vivo, biocatalysis takes place in compartmentalized cellular structure as highly organized particle and membrane systems. This allows control of enzyme-catalyzed reactions. Several multienzyme systems have been studied by many researchers. They consist essentially of membrane- [104] and matrix- [105,106] bound enzymes or coupled enzymes in low water media [107]. 

Figure 3.16 Effects of substrate buildup in a metabolic pathway on the inhibition of an enzyme by competitive (closed circles) and uncompetitive (open circles) inhibitors of equal affinity for the target enzyme.

In Fig. 5, the biosynthetic pathways for the production of PHA with novel composition of hydroxyalkanoates and the enzymes involved are shown. The level of metabolic intermediates, which is determined by the cellular metabolic activities, is important for the synthesis of a desired PHA. Having the engineered metabolic pathways at hand, PHA synthase plays an important role affecting the composition of PHAs, because of substrate specificity of PHA synthase. 

In the above-mentioned examples, the prediction of CYP-mediated compound interactions is a starting point in any metabolic pathway prediction or enzyme inactivation. This chapter presents an evolution of a standard method [1], widely used in pharmaceutical research in the early-ADMET (absorption, distribution, metabolism, excretion and toxicity) field, which provides information on the biotransformations produced by CYP-mediated substrate interactions. The methodology can be applied automatically to all the cytochromes whose 3 D structure can be modeled or is known, including plants as well as phase II enzymes. It can be used by chemists to detect molecular positions that should be protected to avoid metabolic degradation, or to check the suitability of a new scaffold or prodrug. The fully automated procedure is also a valuable new tool in early-ADMET where metabolite- or mechanism based inhibition (MBI) must be evaluated as early as possible. 

Similar to Eq. (67), the first reaction (incorporating the enzyme phosphofructo-kinase) exhibits a Hill-type inhibition by its substrate ATP [126]. The overall ATP utilization v3 (ATP) is modeled by a saturable Michaelis Menten function. The system is specified by five kinetic parameters (with Gx lumped into Vm ), the Hill coefficient n, and the total concentration, 4 / = [ATP] + [ADP]. Note that the model is not intended to capture biological realism, rather it serves as a paradigmatic example to identify dynamic behavior in metabolic pathways. 

Allosteric enzymes show various activation and inhibition effects which are competitive in nature and related to conformational changes in the structure of the enzyme. Such allosteric enzymes are often crucial enzymes in metabolic pathways and exert control over the whole sequence of reactions. The name allostery refers to the fact that inhibition of the enzyme is by substances that are not similar in shape to the substrate. 

The term intermediary metabolism is used to emphasize the fact that metabolic processes occur via a series of individual chemical reactions. Such chemical reactions are usually under the control of enzymes which act upon a substrate molecule (or molecules) and produce a product molecule (or molecules) as shown in Figure 1.1. The substrates and products are referred to collectively as intermediates or metabolites . The product of one reaction becomes the substrate for another reaction and so the concept of a metabolic pathway is created. 

Figure 1.1 Simple representation of a metabolic pathway. Compound B is the product of the first reaction and the substrate for the second reaction, and so on. Capital symbols represent metabolic intermediates and lower case letters with the suffix ase represent enzymes...

The student should be aware that a pathway is essentially a conceptual model developed by biochemists in order to represent the flow of compounds and energy through metabolism. Such models are simply ways of trying to explain experimental data. A potential problem in representing metabolic pathways as in Figure 1.1 is that there is an implication that they are physically and/or topographically organized sequences. This is not necessarily true. With some exceptions (described in Section 1.3), most enzymes are likely to be found free within the cytosol or a compartment of a cell where reactions occur when an enzyme and its substrate meet as a result of their own random motion. Clearly this would be very inefficient were it not for the fact that cells contain many copies of each enzyme and many molecules of each type of substrate. 

We think about metabolic pathways as linear or cyclical sequences of reactions as described in Chapter 1. Individual reactions within a pathway are often dependant upon at least one other reaction. For example, we know from our studies of enzyme kinetics in Chapter 2 that the rate of an enzyme catalysed reaction is determined in part by the concentration of substrate. Remember, the substrate for one reaction is usually the product of a previous reaction, so the activity of an enzyme is affected by the activity of the preceding enzyme in the sequence. 

---